MARKET

CYRX

CYRX

Cryoport Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

23.26
+0.24
+1.04%
After Hours: 23.26 0 0.00% 16:17 05/19 EDT
OPEN
22.91
PREV CLOSE
23.02
HIGH
23.85
LOW
22.74
VOLUME
340.97K
TURNOVER
--
52 WEEK HIGH
86.30
52 WEEK LOW
19.82
MARKET CAP
1.15B
P/E (TTM)
-3.8063
1D
5D
1M
3M
1Y
5Y
B. Riley Lowers Cryoport's Price Target to $55 from $61 to Reflect Updated Required Returns, Keeps Buy Rating
MT Newswires · 2d ago
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 807 companies reached new 52-week lows.
Benzinga · 05/11 16:28
Expert Ratings for CryoPort
Over the past 3 months, 5 analysts have published their opinion on CryoPort (NASDAQ:CYRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the ...
Benzinga · 05/06 14:03
--KeyBanc Adjusts Cryoport's Price Target to $52 from $92, Keeps Overweight Rating
MT Newswires · 05/06 12:46
--Needham Adjusts Cryoport's Price Target to $41 From $45, Reiterates Buy Rating
MT Newswires · 05/06 07:39
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -55% and 0.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/05 23:05
BRIEF-Cryoport Q1 Loss Per Share $0.31
reuters.com · 05/05 23:01
CryoPort Q1 EPS $(0.31) Misses $(0.22) Estimate, Sales $52.80M Miss $52.86M Estimate
CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.22) by 40.91 percent. This is a 138.46 percent decrease over losses of $(0.13) per share from the
Benzinga · 05/05 20:58
More
No Data
Learn about the latest financial forecast of CYRX. Analyze the recent business situations of Cryoport Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

44.44%Strong Buy
55.56%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average CYRX stock price target is 52.56 with a high estimate of 67.00 and a low estimate of 41.00.
High67.00
Average52.56
Low41.00
Current 23.26
EPS
Actual
Estimate
-4.37-3.28-2.18-1.09
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 283
Institutional Holdings: 55.63M
% Owned: 112.67%
Shares Outstanding: 49.38M
TypeInstitutionsShares
Increased
72
4.27M
New
45
1.71M
Decreased
71
3.52M
Sold Out
24
623.82K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Courier, Postal, Air Freight & Land-based Logistics
-2.00%
Freight & Logistics Services
-2.03%
Key Executives
Chairman/President/Chief Executive Officer/Director
Jerrell Shelton
Chief Financial Officer/Senior Vice President/Chief Administrative Officer
Robert Stefanovich
Senior Vice President/Chief Scientific Officer
Mark Sawicki
Lead Director/Independent Director
Richard Berman
Independent Director
Linda Baddour
Independent Director
Daniel Hancock
Independent Director
Robert Hariri
Independent Director
Ram Jagannath
Independent Director
Ramkumar Mandalam
Independent Director
Edward Zecchini
No Data
No Data
About CYRX
Cryoport, Inc. (Cryoport), is a life sciences services company that is an integral part of the supply chain supporting the biopharma, reproductive medicine and animal health markets. Through its products and services, the Company enables its clients to ship, store and deliver cellular-based materials and drug products as well as other life sciences commodities in a precise, defined temperature-controlled state. The Company’s advanced platform is comprised of comprehensive and technology-centric systems and solutions are designed to support the global high-volume distribution of commercial biologic and cell-based products and therapies regulated by the United States Food and Drug Administration (FDA) and other international regulatory bodies for distribution in the Americas, Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC) regions. The Company’s subsidiaries include Cryoport Systems, Inc., MVE Biological Solutions, CRYOPDP and Cryogene Partners.

Webull offers kinds of CryoPort Inc stock information, including NASDAQ:CYRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CYRX stock methods without spending real money on the virtual paper trading platform.